The hypertension medicine Blutforde was certified in Austria at the beginning of 2023. The pharmaceutical form of the medicine is gelatin-coated capsules intended for oral administration by adults. Capsules in the amount of 20 pieces are packaged in a plastic bottle and a cardboard box. The kit includes instructions for use, including a section with contraindications. Before using capsules, read these instructions.
Blutforde capsules have a concentrated composition with active substances that tend to accumulate in the body. To obtain the best result, it is necessary to take the medicine without interruption for 30 days. If necessary, the admission period can be increased to 60 days. It is necessary to take the capsules twice a day, the recommended time is in the morning and in the evening after meals. It is advisable that approximately 6-8 hours pass between doses. The capsules are washed down with clean still water, on average 100-150 ml of water is required; The gelatin shell begins to dissolve in the stomach, after which the components of the composition are absorbed and enter the circulatory system. Do not take two capsules at a time. Although no side effects and allergic reactions have been recorded, exceeding the recommended dose may cause additional stress on the endocrine and excretory systems.
An additional advantage of Blutforde capsules is that they can be used alone or in combination with other medications. Moreover, not only a course is possible, but also a single use, for example, to reduce blood pressure during stress. You can also take them to prevent high blood pressure when the first symptoms of high blood pressure appear. In this case, you can drink it once a day for two weeks. This is enough to restore the normal functionality of the cardiovascular system and normalize metabolic processes. Before use, make sure you have signs of hypertension, which may be an indication for use.
The medicine is contraindicated in case of individual intolerance to the components of the composition, during the last trimester and lactation, in case of oncological diseases of the gastrointestinal tract and organic lesions of the heart or brain. It is not recommended to administer to children under 12 years of age and people over 80 years of age.
